News | Computed Tomography (CT) | September 03, 2015

Non-Invasive FFR-CT Reduces Invasive Tests in Chest Pain Patients

Sixty-one percent of patients in PLATFORM trial had invasive tests canceled following FFR-CT analysis

FFR-CT, HeartFlow, PLATFORM trial, ESC 2015, ICA, fractional flow reserve, computed tomography

Image courtesy of HeartFlow

September 3, 2015 — Results of the PLATFORM trial indicate fractional flow reserve computed tomography (FFR-CT) can obviate the need for invasive tests in up to 61 percent of patients with chest pain and suspected coronary artery disease. The results were presented at the European Society of Cardiology (ESC) Congress 2015.

FFR-CT estimates blood flow and pressure in the coronary artery using images from computed tomography angiography (CTA).

“This approach significantly reduced the need for unnecessary invasive coronary angiography (ICA) which, although it is the gold standard for investigating chest pain, comes with the risk and costs of an invasive procedure,” said lead investigator Pamela Douglas, M.D., the Ursula Geller Professor at the Duke Clinical Research Institute, Duke University School of Medicine.

“The message is that for stable chest pain patients in whom elective ICA is recommended, consideration should be given to performing this new test first.”

When used alone, CTA can identify an abnormal narrowing (stenosis) in the coronary arteries but it cannot quantify how much this actually obstructs blood flow. Therefore “many patients who have blockages that are not interfering with blood flow may end up undergoing ICAs that show no evidence of obstructive coronary artery disease (CAD) and could possibly have been avoided, “ explained Douglas.

Other commonly used non-invasive tests for CAD, such as myocardial perfusion stress imaging or stress echocardiography, may tell whether blood supply to the heart tissue is adequate but cannot determine whether a specific blockage is obstructing blood flow, she said.

The current standard for assessing the significance of coronary artery narrowing is conventional FFR, which is invasive, involving insertion of a wire into the coronary artery.

But by using computer simulations to calculate blood flow, non-invasive FFR-CT can give a comprehensive evaluation of a patient’s chest pain without the need for an invasive procedure.

The PLATFORM study included 584 chest pain patients (average age 60.9 years) from 11 test centers in Europe.

Patients were evaluated using either FFR-CT, via the HeartFlow FFR-CT Analysis software from HeartFlow (n=297), or conventional testing (n=287) to see if FFR-CT  could reduce the rate of ICAs that show no obstructive CAD.

Patients were divided into those in whom “usual care” would dictate a non-invasive investigation such as stress testing or conventional CTA (n=204) and those who would have proceeded straight to an invasive ICA (n=380).

In both groups patients were then allocated to receive either usual care (invasive or non-invasive) or FFR-CT — defined as CTA with the addition of FFR when appropriate.

Among patients already scheduled for an ICA, 73 percent in the usual care group underwent ICA only to find no significant blockages, compared to 12 percent in the FFR-CT group. Furthermore, 61 percent of patients in the FFR-CT group had the ICA cancelled based on the FFR-CT results.

While FFR-CT reduced the number of patients who underwent an ICA that found no significant disease, there was no difference between the two groups in the rate of revascularization procedures, such as stenting and coronary artery bypass surgery.

No clinical adverse events were reported at the 90-day follow-up in patients whose physicians chose to cancel ICAs based on FFR-CT guided strategy

“The study shows that CTA plus FFR-CT more effectively triages patients for invasive procedures than usual care strategies,” said Douglas.

“Although FFR-CT is a relatively new technique, PLATFORM demonstrates that it is feasible and safe with high utility in busy clinical settings.” 

FFR-CT from HeartFlow received CE Mark in 2010 and received U.S. Food and Drug Administration clearance in November 2014. The technology has been evaluated in four large, clinical trials enrolling a total of more than 1,100 patients

For more information: www.escardio.org

Related Content

Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT) | September 15, 2017
September 15, 2017 — Hitachi Healthcare Americas Inc. announced it has attained U.S.
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT) | September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Intronix Technologies Developing Augmented Reality Medical Simulation for Neuromuscular Injection Procedures
News | Advanced Visualization | September 11, 2017
Canadian-based Intronix Technologies will be working with Roy Eagleson, Ph.D., professor in the Department of...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology and has prompted the implementation of radiation dose monitoring systems.
Feature | Radiation Dose Management | September 08, 2017 | By Dave Fornell
Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology and has prompted the...
Overlay Init